BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30021770)

  • 1. Pre-Existing Maternal Antibodies Cause Rapid Prenatal Rejection of Allotransplants in the Mouse Model of In Utero Hematopoietic Cell Transplantation.
    Riley JS; McClain LE; Stratigis JD; Coons BE; Li H; Hartman HA; Peranteau WH
    J Immunol; 2018 Sep; 201(5):1549-1557. PubMed ID: 30021770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice.
    Merianos DJ; Tiblad E; Santore MT; Todorow CA; Laje P; Endo M; Zoltick PW; Flake AW
    J Clin Invest; 2009 Sep; 119(9):2590-600. PubMed ID: 19652363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.
    Peranteau WH; Endo M; Adibe OO; Merchant A; Zoltick PW; Flake AW
    Blood; 2006 Dec; 108(13):4268-74. PubMed ID: 16954501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model.
    Shi C; Li Z; Sun Z; Pan L
    Transplant Cell Ther; 2024 Apr; 30(4):398.e1-398.e10. PubMed ID: 38331194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
    Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
    Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment.
    Shaaban AF; Kim HB; Gaur L; Liechty KW; Flake AW
    Exp Hematol; 2006 Sep; 34(9):1278-87. PubMed ID: 16939821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation.
    Kandasamy K; Tan LG; B Johana N; Tan YW; Foo W; Yeo JSL; Ravikumar V; Ginhoux F; Choolani M; Chan JKY; Mattar CNZ
    FASEB J; 2021 Mar; 35(3):e21413. PubMed ID: 33570785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition.
    Kim AG; Vrecenak JD; Boelig MM; Eissenberg L; Rettig MP; Riley JS; Holt MS; Conner MA; Loukogeorgakis SP; Li H; DiPersio JF; Flake AW; Peranteau WH
    Blood; 2016 Nov; 128(20):2457-2461. PubMed ID: 27650329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
    Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
    Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero.
    Ihara N; Akihiro U; Onami N; Tsumura H; Inoue E; Hayashi S; Sago H; Mizutani S
    Congenit Anom (Kyoto); 2015 Feb; 55(1):55-64. PubMed ID: 25421592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.
    Vrecenak JD; Pearson EG; Santore MT; Todorow CA; Li H; Radu A; Bhatti T; Peranteau WH; Johnson MP; Flake AW
    Blood; 2014 Sep; 124(12):1987-95. PubMed ID: 24869940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation.
    Donahue J; Gilpin E; Lee TH; Busch MP; Croft M; Carrier E
    Transplantation; 2001 Feb; 71(3):359-68. PubMed ID: 11233894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice.
    Nijagal A; Wegorzewska M; Jarvis E; Le T; Tang Q; MacKenzie TC
    J Clin Invest; 2011 Feb; 121(2):582-92. PubMed ID: 21245575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Intravenous Route of Injection Optimizes Engraftment and Survival in the Murine Model of In Utero Hematopoietic Cell Transplantation.
    Boelig MM; Kim AG; Stratigis JD; McClain LE; Li H; Flake AW; Peranteau WH
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):991-999. PubMed ID: 26797401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice.
    Bhattacharyya S; Chawla A; Smith K; Zhou Y; Talib S; Wardwell B; Cowan MJ
    J Immunol; 2002 Dec; 169(11):6133-40. PubMed ID: 12444116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
    Hayashi S; Peranteau WH; Shaaban AF; Flake AW
    Blood; 2002 Aug; 100(3):804-12. PubMed ID: 12130490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.
    Peranteau WH; Hayashi S; Abdulmalik O; Chen Q; Merchant A; Asakura T; Flake AW
    Blood; 2015 Sep; 126(10):1245-54. PubMed ID: 26124498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.